These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19630810)

  • 21. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
    Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
    J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic basis of heparin-induced thrombocytopenia.
    Poncz M
    Semin Thorac Cardiovasc Surg; 2005; 17(1):73-9. PubMed ID: 16104364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Autoimmun Rev; 2002 May; 1(3):125-32. PubMed ID: 12849005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia.
    Weimann G; Lubenow N; Selleng K; Eichler P; Albrecht D; Greinacher A
    Eur J Haematol; 2001 Mar; 66(3):195-9. PubMed ID: 11350488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
    Newman PM; Chong BH
    Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
    Horne MK; Hutchison KJ
    Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
    Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
    Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
    Ziporen L; Li ZQ; Park KS; Sabnekar P; Liu WY; Arepally G; Shoenfeld Y; Kieber-Emmons T; Cines DB; Poncz M
    Blood; 1998 Nov; 92(9):3250-9. PubMed ID: 9787161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia.
    Arepally GM
    Blood; 2017 May; 129(21):2864-2872. PubMed ID: 28416511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet binding of IgG from patients with heparin-induced thrombocytopenia.
    Horne MK; Alkins BR
    J Lab Clin Med; 1996 May; 127(5):435-42. PubMed ID: 8621980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
    Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
    Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).
    Cai Z; Zhu Z; Greene MI; Cines DB
    Autoimmun Rev; 2016 Jul; 15(7):752-5. PubMed ID: 26970483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
    Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
    Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.
    Li ZQ; Liu W; Park KS; Sachais BS; Arepally GM; Cines DB; Poncz M
    Blood; 2002 Feb; 99(4):1230-6. PubMed ID: 11830470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating anti-PF4 disorders: An overview.
    Warkentin TE
    Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
    Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
    Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
    Blank M; Cines DB; Arepally G; Eldor A; Afek A; Shoenfeld Y
    Clin Exp Immunol; 1997 May; 108(2):333-9. PubMed ID: 9158107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.